MetLife Investment Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$504K Hold
41,050
﹤0.01% 1671
2025
Q1
$903K Sell
41,050
-699
-2% -$15.4K ﹤0.01% 1422
2024
Q4
$947K Buy
41,749
+2,111
+5% +$47.9K 0.01% 1446
2024
Q3
$720K Buy
39,638
+22,334
+129% +$406K ﹤0.01% 1581
2024
Q2
$504K Sell
17,304
-20,063
-54% -$585K ﹤0.01% 1716
2024
Q1
$1.32M Sell
37,367
-985
-3% -$34.9K 0.01% 1147
2023
Q4
$1.67M Sell
38,352
-2,246
-6% -$97.8K 0.01% 1023
2023
Q3
$1.55M Sell
40,598
-2,107
-5% -$80.5K 0.01% 1019
2023
Q2
$1.76M Sell
42,705
-1,844
-4% -$75.8K 0.01% 984
2023
Q1
$2.56M Sell
44,549
-1,193
-3% -$68.5K 0.02% 828
2022
Q4
$2.56M Sell
45,742
-908
-2% -$50.9K 0.02% 793
2022
Q3
$1.98M Buy
46,650
+137
+0.3% +$5.8K 0.02% 881
2022
Q2
$2.51M Sell
46,513
-583
-1% -$31.5K 0.02% 805
2022
Q1
$3.03M Buy
47,096
+11,796
+33% +$758K 0.02% 808
2021
Q4
$2.36M Buy
35,300
+356
+1% +$23.8K 0.02% 808
2021
Q3
$2.39M Sell
34,944
-543
-2% -$37.2K 0.02% 777
2021
Q2
$2.42M Sell
35,487
-1,120
-3% -$76.4K 0.02% 791
2021
Q1
$2.53M Sell
36,607
-2,130
-5% -$147K 0.02% 767
2020
Q4
$2.51M Sell
38,737
-1,791
-4% -$116K 0.02% 716
2020
Q3
$1.91M Sell
40,528
-1,291
-3% -$61K 0.02% 741
2020
Q2
$1.97M Buy
41,819
+910
+2% +$42.8K 0.02% 720
2020
Q1
$1.83M Hold
40,909
0.02% 645
2019
Q4
$2.38M Sell
40,909
-382
-0.9% -$22.3K 0.02% 740
2019
Q3
$2.48M Sell
41,291
-741
-2% -$44.5K 0.03% 700
2019
Q2
$2.35M Sell
42,032
-1,090
-3% -$60.9K 0.03% 739
2019
Q1
$2.4M Buy
43,122
+13
+0% +$724 0.03% 736
2018
Q4
$1.94M Sell
43,109
-151
-0.3% -$6.81K 0.02% 770
2018
Q3
$2.85M Sell
43,260
-1,076
-2% -$70.9K 0.03% 696
2018
Q2
$2.86M Buy
44,336
+15,286
+53% +$985K 0.03% 649
2018
Q1
$1.61M Hold
29,050
0.02% 844
2017
Q4
$1.39M Buy
+29,050
New +$1.39M 0.02% 899